EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel peptide calcitonin gene-related peptide antagonists for migraine therapy

Patrick M Killoran, Vicky Capel, Vera D'Aloisio, Adam Schofield, Tímea Aczél, Kata Bölcskei, Zsuzsanna Helyes, Bengt von Mentzer, David A Kendall, Chris R Coxon, Gillian A Hutcheon iD

Journal of Pharmacy and Pharmacology · 01.12.2023 · 75 (12) · 1581-1589

DOI: 10.1093/jpp/rgad081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.12.2023. Verfasst von Patrick M Killoran und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Migraine Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovate UK, Liverpool John Moores University, National Research, Development and Innovation Office of Hungary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

It has previously been shown that the peptide (34Pro,35Phe)CGRP27–37 is a potent calcitonin gene-related peptide, CGRP receptor antagonist, and in this project we aimed to improve the antagonist potency through the structural modification of truncated C-terminal CGRP peptides.

Methods

Six peptide analogues were synthesized and the anti-CGRP activity confirmed using both in vitro and in vivo studies. Key findings A 10 amino acid-containing peptide VPTDVGPFAF-NH2 (P006) was identified as a key candidate to take forward for in vivo evaluation, where it was shown to be an effective antagonist after intraperitoneal injection into mice. P006 was formulated as a preparation suitable for nasal administration by spray drying with chitosan to form mucoadhesive microcarriers (9.55 ± 0.91 mm diameter) and a loading of 0.2 mg peptide per 20 mg dose.

Conclusions

The project has demonstrated the potential of these novel small peptide CGRP antagonists, to undergo future preclinical evaluation as anti-migraine therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcitonin Gene-Related PeptideMigraine DisordersMiceAnimalsReceptors, Calcitonin Gene-Related PeptideCalcitonin Gene-Related Peptide Receptor AntagonistsAmino Acids

Stichwörter der Autor:innen

CGRP antagonistchitosan microparticlesmigrainenasal deliverypeptide

Substanzen

Calcitonin Gene-Related PeptideReceptors, Calcitonin Gene-Related PeptideCalcitonin Gene-Related Peptide Receptor AntagonistsAmino Acids

Autor:innen und Institutionen

  • School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom.
  • NHS Health Education England, Victoria House, Fulbourn, Cambridge, CB21 5XB, United Kingdom.
  • AmbioPharm, Inc., 1024 Dittman Court, North Augusta, SC 29842, United States.
  • EaStCHEM School of Chemistry, The University of Edinburgh, Joseph Black Building, David, Brewster Road, Edinburgh, EH14 4AS, United Kingdom.
  • Department of Pharmacology and Pharmacotherapy, University of Pécs Medical School, Szigeti út 12, Pécs, Hungary.
  • Eötvös Lorand Research Network, Chronic Pain Research Group, University of Pécs, Szigeti út 12, Pécs, Hungary.

ORCID-Profile: Gillian A Hutcheon

Förderung

  • Innovate UK
  • Liverpool John Moores University
  • National Research, Development and Innovation Office of Hungary
  • Eötvös Lóránd Research Network

Zitieren

APA

Killoran, P. M., Capel, V., D'Aloisio, V., Schofield, A., Aczél, T., Bölcskei, K., Helyes, Z., von Mentzer, B., Kendall, D. A., Coxon, C. R., & Hutcheon, G. A. (2023). Novel peptide calcitonin gene-related peptide antagonists for migraine therapy. Journal of Pharmacy and Pharmacology, 75(12), 1581-1589. https://doi.org/10.1093/jpp/rgad081

Vancouver

Killoran PM, Capel V, D'Aloisio V, Schofield A, Aczél T, Bölcskei K, et al. Novel peptide calcitonin gene-related peptide antagonists for migraine therapy. Journal of Pharmacy and Pharmacology. 2023;75(12):1581-1589. doi:10.1093/jpp/rgad081

BibTeX
@article{Killoran2023,
  author = {Killoran, Patrick M and Capel, Vicky and D'Aloisio, Vera and Schofield, Adam and Aczél, Tímea and Bölcskei, Kata and Helyes, Zsuzsanna and von Mentzer, Bengt and Kendall, David A and Coxon, Chris R and Hutcheon, Gillian A},
  title = {Novel peptide calcitonin gene-related peptide antagonists for migraine therapy},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  volume = {75},
  number = {12},
  pages = {1581--1589},
  doi = {10.1093/jpp/rgad081}
}
Kostenlos starten →